chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My event was not adverse... the complete opposite. I have suffered with venous insufficiancy for 30 years to the point I was scheduled for a medical procedure to stop stasis infections in August of 2021. I had my first vaccine in May of 2021 and 2 days later experienced a tingling gurgling sensation at the sight of my disfunctional leg valves. 2 weeks after my vaccine the edema I have suffered for 30 years was all but gone. After my 2nd vaccine in July of 2021 the edema was completely gone. I went for the first of my procedures in August  2021 but my surgery was cancelled because the ultra sound showed that my valves were almost completely functional. A follow up was booked for yesterday July 2022 and the ultra sound now shows that my valves are now 100% functional. The Veinologist told me yesterday that she has never seen a vein valve repair itself with out medical intervention in her career. I am a medical mystery to her at this point. I have also met another person with the same condition who told me they have the same story with a complete reversal of their vein valve disease since they were vaccinated for covid. They too had a long term suffering of this disease/condition for 20 years.
Information has been received from a consumer concerning her daughter on an unspecified date was vaccinated with a dose of MMR II. Subsequently, on an unknown date the patient had a bad reaction to MMR II. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. No further information is available.
Localized swelling, erythema and fatigue/malaise. Treated symptomatically with NSAIDs, Acetaminophen.
March 12, 2021:  10:30am vaccine administered; 10:40am light headed and dizzy for a few min; 10:50am saw stars.  Remained seated and was observed and had some apple juice.  1:30pm began flu like symptoms began:  1) dizzy, 2) headache, 3) chills, 4) body aches, 5) joint pain, 6) exhaustion.    March 23, 2021 still have flu like symptoms and not getting better:  1) dizzy, 2) headache, 3) body aches, 4) joint pain, 5) exhaustion.
Body ache; Nauseous; Eye pain; Joint pain; Chills; hot; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 16:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. The patient did not have any allergies to medications, food or other products. The patient did not receive any other mediations within two weeks prior to vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 03:00, the patient experienced body ache, nauseous, eye pain, joint pain, chills and hot. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body ache, nauseous, eye pain, joint pain, chills and hot were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
24 hours after receiving the vaccine the left arm began to swell and was hot to touch. There was burning sensation at the site.
This spontaneous report as received from a healthcare worker refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with third dose of GARDASIL, dose (unknown) and route of administration (unknown), for unknown indication, that was exposed to temperatures between 32F and 367F for a cumulative time of 2 hours. No concomitant Medications were reported. The patient, who received the improperly stored dose of GARDASIL had not reported any adverse effects. Action taken with respect to GARDASIL was not applicable. No product quality complaint was involved. The outcome of events was unknown. No additional information was provided. Additional information has been requested.
The client received her 1st dose Pfizer and approximately 20 mins. later the client stated she was nausea, dizzy, lightheaded and also vomited. The client was also diaphoretic. The client vital signs were stable upon paramedics arrival. The client stated that she had allergies to prednisone, tomato,  citrus, and shellfish. Client stated her primary care physician would not give her the vaccine. This information was shared after the dose was already given.
Arm was sore, and continued to get worse. Range of motion began to be affected after about 1 week, and within 3 months, I could barely use my arm. I saw my Pain Management Doctor, and had an MRI done, and began getting steroid injections in my left shoulder in September, 2021. I have had a total of 5-6 injections, and have most of the use of my arm. I did some research recently, and realized that what happened to me was exactly like what happens with SIRVA.
Pt hx of Coombs' positive hemolytic anemia, splenectomy & lupus erythematosus, all now under medical control, vaccinated w/pneumococcal vaccine polyvalent.  One wk after vacc. developed "rip roaring" Coombs' positive hemolytic anemia.
Arrhythmia; Heart problem; This spontaneous case was reported by a consumer and describes the occurrence of ARRHYTHMIA (Arrhythmia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARRHYTHMIA (Arrhythmia) (seriousness criterion medically significant) and CARDIAC DISORDER (Heart problem). At the time of the report, ARRHYTHMIA (Arrhythmia) and CARDIAC DISORDER (Heart problem) outcome was unknown.            The patient's concomitant medication was not reported. No treatment information was provided.  The patient experienced heart problem and arrhythmia after second dose.  Company comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Difficulty breathing; headache; dizziness; feeling like going to far not; elevated blood glucose; overall body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Nov2021 16:30 (Batch/Lot number: unknown) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "PTSD" (unspecified if ongoing); "restless legs" (unspecified if ongoing); "CPAP" (unspecified if ongoing); "bipolar schizoeffective" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: covid prior vaccination reported as yes. Concomitant medication(s) included: INVEGA [PALIPERIDONE]; SEROQUEL; PRAMIPEXOLE. Vaccination history included: Bnt162b2 (Dose 2, single; Batch/Lot No: Unknown, Misplaced/discarded; in left arm; at 08:00 AM), administration date: 13Mar2021, when the patient was 46 years old, for COVID-19 Immunization, reaction(s): "Dose 1 09Jan2021; Dose 2 13Mar2021"; Bnt162b2 (Dose 1, single; Batch/Lot No: Unknown, Misplaced/discarded; in right arm; at 08:00 AM), administration date: 09Jan2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: DYSPNOEA (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "Difficulty breathing"; HEADACHE (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "headache"; DIZZINESS (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "dizziness"; FEELING ABNORMAL (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "feeling like going to far not"; BLOOD GLUCOSE INCREASED (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "elevated blood glucose"; PAIN (non-serious) with onset 07Nov2021 12:00, outcome "recovering", described as "overall body aches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dyspnoea, headache, dizziness, feeling abnormal, blood glucose increased, pain. Additional information: Known allergies was reported as yes. Facility where the most recent COVID-19 vaccine was administered in Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination reported as Invega, Seroquel pramipexole mipraxole magnesium v. Patient had covid test post vaccination was reported as nasal swab test with negative result on 08Nov2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Nov2022 as dose 5 (booster), single (Lot number: GLO446) at the age of 65 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Apr2021 as dose  2, single (Lot number: EWO150, Expiration Date: Jul2021), in left arm, on 05Oct2021 as dose 3 (booster), single (Lot number: 301258), in left arm and on 05Jun2022 as dose 4 (booster), single (Lot number: FMU173), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Throat cancer", start date: 2017 (unspecified if ongoing), notes: fully recovered, no lymph nodes in left side of neck/chest. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: No Known allergies. Patient received Paxlovid for Treatment of COVID-19.  No follow-up attempts are possible. No further information is expected.
Had to use bathroom in the middle of the night and I became really dizzy, started sweating and then fell onto the bathroom floor.  Crawled back to bed and continued to feel bad until about 9 am.  Then I was just really tired the rest of the day.
Three days post vax, this pt reported an injection site reaction, characterized by a 4-inch area of redness, pain, and induration. The pt recovered. This is 1 of 2 pts from this facility who had an adverse experience following receipt of TD.
Information has been received from a physician concerning unspecified number of patients who "about a year ago" were vaccinated with PNEUMOVAX (lot number 655289/0958F).  Subsequently the patients experienced painful swelling on the injection site.  The patients had sought medical attention from the physician. The outcome of the unspecified number of patient's adverse effect was not reported.  Attempts are being made to obtain number of patients and additional identifying information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.
In 04/00, the pt developed a 1 cm by 2 cm red dermal nodule that was fairly soft superficially, but indurated deeper in the dermis of the vaccination site. In 06/00, a course of Cephalexin was tried and failed. In approximately 9/00 or 10/00, the pt was referred to a dermatologist who treated the red nodule with desoximetasone 0.25% emollient cream (TOPICORT Cream). The nodule was present for 5 months and resolved to a flat scar, still indurated like a "dermato fibroma" within 1 month of treatment with desoximetasone 0.25% emollient cream (Topicort Cream) in 08/02. It was reported that the patient (WAES01012173) had a similar experience following exposure to Varivax. Additional information is not excpected.
Fever for 5 days , stopped with appearance of rash on face and trunk. diarrhea started 10/5/01. Tx with TMP-PMZ for 4 to day 5. Rash and course typical of roseola.
One week after receiving the shot, the injection site on left arm became red, raised, and itchy for about 36 hours, not treated. Slight fever during the same time, treated with acetaminophen. Both resolved within 36 hours.
The patient was seen to catch up on immunizations and based on the patient's vaccination card, it showed that he was missing his third hepatitis B vaccine so it was given on 12/04/22. However, when inputting vaccines into system, the patient's account was found which showed that he did received his third hepatitis B vaccine on 4/01/2022, it was just not added to his vaccination card so he received an extra dose.
Headache; Neck pain; Bilateral arm pain; Hot/cold flashes; Hot/cold flashes; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 22Apr2021 at 09:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 01Apr2021 at 11:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 21:00, the patient experienced headache, neck pain, bilateral arm pain and hot/cold flashes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, neck pain, bilateral arm pain and hot/cold flashes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
This is a concern given the timing of the onset of the second disease.  There is no proof of any association but I feel that the condition is so rare that the timing of the Zostavax vaccination needs to be at least mentioned. The patient and her husband received Zostavax injections in Nov 2012.  The patient developed a small localized erythematous reaction but her husband developed a full shingles reaction/rash to his right forehead which then cleared without event. In late January 2012 the patient started coming in with complaints about fullness in her ears, sinus congestion.  She was treated with antibiotics and finally prednisone.  While on prednisone she started to develop neurologic deficits in 3-15-13 that eventually progressed into major neurologic deficits and finally the diagnosis of Creutzfeld-Jacob Disease via MRI, EEG, and CSF evaluation.  The patient is receiving comfort care at home as I write this and is expected to die within the next week. I am just concerned about the timing of the vaccination and then onset of symptoms and then diagnosis of CJD within 5 months.
extreme pain @ inj resulting in inability to move arm;feels crackling @ shoulder joint;use of warm compresses & Ibuprofen does not help;MD indicates pt has full ROM & soreness r/t vax;
general body pain; migraine; nausea; a low grade fever of 99; it "hit her like a bus"; This is a spontaneous report from a contactable consumer (patient's sister).  A 41-year-old female patient (not pregnant) received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown), via an unspecified route of administration on Jan2021 at the age of 41-year-old at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. She had no covid prior vaccination. Patient previously received first dose BNT162B2 on Dec2020 at single dose for covid-19 immunisation. She had received her second dose of vaccine and it "hit her like a bus", she experienced general body pain, migraine, nausea, and a low grade fever of 99 on Jan2021. Outcome of events was unknown.   Information on lot/batch number has been requested.
Local swelling, fever, redness, extreme pain and immobility of left arm progressive throughout 6/26/2019 and then no better on 6/27/19 went to ER
At 1050 Patient reported that she was feeling "weird" states that she felt like her chest and arms were tingling. We sat her down and asked her if she had ever felt this way before and she stated that once she had a medication that made her break out in a rash that started out with tingling but eventually got worst. Nurse at this time recommended to patient that she should stay for 30 mins for further observation, patient refused. When questioned patient denied itchiness, shortness of breath, or any other symptoms except for tingling. Nurse offered benadryl prior to her leaving and she agreed, dose administered at 1058. At 1100 patient left the premises. At 1445 Nurse called patient with CDC recommendation that she does not receive her second dose of Moderna per her reaction. Patient stated that she wants to continue with receiving her second dose because as soon as she "took off her tight brawl" the symptoms went away. Patient does not believe symptoms were related to vaccine. Patient denied having any further symptoms; rash, shortness of breath, or further tingling at this time.
Information has been received from a physician concerning an 8 year old boy who on 12-MAY-2008 was vaccinated with the second dose of VARIVAX (Merck) subcutaneously (lot#: 659726/1772U). There was no concomitant medication. Two weeks after vaccination (on 26-MAY-2008) the patient developed chickenpox rash all over the body. But the patient had no fever. As of 27-MAY-2008, the patient recovered. The patient was seen by the physician. Additional information has been requested.
About 40 min after vaccine patient became hot, weak, light-headed. Pain started from shoulders to feet, feeling "like someone was beating her up." Pain left after 3 hrs. Patient left worn out.
Mom called saying pt developed hives and profuse vomiting.  Mom treated with Benadryl with improvement in symptoms.
about 8 days after vaccination, began to have itching at the injection site, and the next day, pain in the arm.  Also, malaise, felt chilled, but no temp.
Information has been received from a certified medical assistant concerning a 21 year old white female with no pertinent medical history who on 26-JUN-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot #0469U).  Concomitant therapy included an unspecified anti-histamine and ADVIL.  Subsequently, the patient experienced redness and swelling on right hand and a sharp shooting pain in left lower quadrant of pelvic area.  Subsequently, the patient recovered.  On 28-AUG-2007, the patient was vaccinated into the right deltoid with a second dose of Gardasil (lot #0469U).  On 28-AUG-2007 the patient experienced shooting pain in left lower quadrant of pelvic area, swelling and redness on right hand.  The patient called the physician's office on 28-AUG-2007.  On 28-AUG-2007 the patient recovered from redness and swelling of the right hand after about one hour, on approximately 31-AUG-2007 after 1-4 days she recovered from the sharp shooting pain in the left lower pelvic region. Additional information is not expected.
a) Rapid heart beat (up to 140/min.) immediately after vaccination. Heart rate normalized after half hour of rest. b) Acid reflux three days after vaccination. Took Omeprozole & Sucralfate tabs and recovered within 3 weeks. c). Tachycardia & palpitation occurred on 4/12/2021. Hard to fall asleep at night. Visited ER, no treatment (blood test, chest X-ray and EKG all normal).   d).  Excessive fatigue following just a few steps of walk, or speaking just a brief moment. Began to be sensitive to screen light and sound from loudspeakers. e). Hospitalized on 4/16/2021, b/c of breathing problem, numbness (hands & feet) and muscle cramps. Called 911 for ambulance to hospital. Discharged on 4/18/2021 after testing normal for chest X-ray, EKG, echocardiogram. Prescribed Bisoprolol Fumarate tabs.  f). After discharge from hospital, I had to remain on bed b/c of breathing difficulty upon standing up or slight movement. Excessive sweat during sleep or after meals. g). Subsequently I felt a little better and began to do minor exercises (walking in the yard) May 14-19.  While lying on the bed on the night of May 19, I felt short of breath and worsening of breathing patterns (i.e. shallow breathing). h) On May 23, I began to feel shortness of breath when I walk or after a meal. i) Staring May 24th, I felt very weak breathing when lying on bed. Since then, I have experienced weaker & weaker tidal volume. j) Staring May 27th, I felt shallow breathing when I was at rest during the day. Since then, I have experienced weaker & weaker tidal volume.
Patient reported dizziness, nausea and cramping 30 minutes after vaccination administration.  Pt reports that dizziness was gone after 30 minutes, but continued to have intermittent nausea. Site of injection site clear, no redness or swelling.
Narrative:  required 2 emergency room visits and 1 urgent care  visit due to symptoms of generalized urticaria, trouble breathing, throat swelling
This case was reported by a nurse and described the occurrence of swelling of the arm of a 3 year old female pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 15Oct2003, the pt received the 5th dose of Infanrix in her left arm. The following day, on 16Oct2003, the pt developed swelling and blistering of her left arm from the injection site to her elbow. The pt was seen at the physician's office and treated with an unspecified antibiotic, ibuprofen, and steroids. The events resolved approximately five days later, on 20Oct2003. The reporter considered the events to be possibly related to vaccination with Infanrix.
This case was reported by a nurse and described the occurrence of limb swelling in a 18 month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 7/14/03, the patient received Infanrix. On 7/15/03, one day post immunization, the patient experienced limb swelling and an injection site reaction characterized by redness and warmth. The outcome of the events is unknown.